Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;12(5):1144-1152.
doi: 10.1002/jcsm.12747. Epub 2021 Jun 17.

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

Affiliations

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

Han Gyul Yoon et al. J Cachexia Sarcopenia Muscle. 2021 Oct.

Abstract

Background: Excessive skeletal muscle loss during neoadjuvant concurrent chemoradiotherapy (NACRT) is significantly related to survival outcomes of oesophageal cancer. However, the conventional method for measuring skeletal muscle mass requires computed tomography (CT) images, and the calculation process is labour-intensive. In this study, we built machine-learning models to predict excessive skeletal muscle loss, using only body mass index data and blood laboratory test results.

Methods: We randomly split the data of 232 male patients treated with NACRT for oesophageal cancer into the training (70%) and test (30%) sets for 1000 iterations. The naive random over sampling method was applied to each training set to adjust for class imbalance, and we used seven different machine-learning algorithms to predict excessive skeletal muscle loss. We used five input variables, namely, relative change percentage in body mass index, albumin, prognostic nutritional index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio over 50 days. According to our previous study results, which used the maximal χ2 method, 10.0% decrease of skeletal muscle index over 50 days was determined as the cut-off value to define the excessive skeletal muscle loss.

Results: The five input variables were significantly different between the excessive and the non-excessive muscle loss group (all P < 0.001). None of the clinicopathologic variables differed significantly between the two groups. The ensemble model of logistic regression and support vector classifier showed the highest area under the curve value among all the other models [area under the curve = 0.808, 95% confidence interval (CI): 0.708-0.894]. The sensitivity and specificity of the ensemble model were 73.7% (95% CI: 52.6%-89.5%) and 74.5% (95% CI: 62.7%-86.3%), respectively.

Conclusions: Machine learning model using the ensemble of logistic regression and support vector classifier most effectively predicted the excessive muscle loss following NACRT in patients with oesophageal cancer. This model can easily screen the patients with excessive muscle loss who need an active intervention or timely care following NACRT.

Keywords: Machine learning; Nutrition; Oesophageal cancer; Sarcopenia; Skeletal muscle loss.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any conflict of interest to disclose.

Figures

Figure 1
Figure 1
Process of calculating the 95% confidence interval of statistics.
Figure 2
Figure 2
Visualization of the data distribution using the uniform manifold approximation and projection algorithm. The number of neighbours and random state value were set to 15 and 0, respectively.
Figure 3
Figure 3
Sensitivity and specificity according to the probability threshold for excessive skeletal muscle loss.

References

    1. Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol 2017;18:843–850. - PubMed
    1. Roy P, Chowdhury S, Roy HK. Exercise‐induced myokines as emerging therapeutic agents in colorectal cancer prevention and treatment. Future Oncol 2018;14:309–312. - PubMed
    1. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL‐6 enhances plasma IL‐1ra, IL‐10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003;285:E433–E437. - PubMed
    1. Lucia A, Ramirez M. Muscling in on cancer. N Engl J Med 2016;375:892–894. - PubMed
    1. Basile D, Parnofiello A, Vitale MG, Cortiula F, Gerratana L, Fanotto V, et al. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients. J Cachexia Sarcopenia Muscle 2019;10:368–377. - PMC - PubMed